Aislinn Antrim, Assistant Editor

New research has found that hospitalized patients with COVID-19, diabetes, and/or uncontrolled hyperglycemia have significantly higher mortality rates.

Pharmacy students pursuing residency programs should consider their strengths and goals.

The JAVELIN trial is a randomized, open-label, phase 3 trial comparing avelumab in combination with chemotherapy versus chemotherapy alone.

The widely available anti-parasitic drug ivermectin is capable of killing COVID-19 within 48 hours in a cell culture, according to a new study.

The JAVELIN trial is a randomized, open-label, phase 3 trial comparing avelumab in combination with chemotherapy versus chemotherapy alone.

Pharmacy students have more career options than they may realize, according to pharmacy professionals at a presentation held at the ASHP 54th Midyear Clinical Meeting and Exhibition.

Although chloroquine and hydroxychloroquine have been touted as potential treatments for COVID-19, physicians in Italy have warned that the global supply may not be able to keep up with demand.

Demcizumab is a DLL4-targeted lgG2 humanized monoclonal antibody and a potent inhibitor of the Notch pathway.

The investigators from the University of Michigan emphasized that COVID-19 may not necessarily behave like other coronaviruses and influenza outbreaks.

As investigators continue to study the use of drugs such as remdesivir for the treatment of the COVID-19 pandemic, some researchers are considering drug repurposing as a temporary solution.

Experts in Idaho are hoping that the state’s broad practice laws for pharmacists and technicians will provide a blueprint for other states looking to expand pharmacists’ capabilities.

Pharmacists on the frontlines of the pandemic need to be aware of the latest science and recommendations in order to accurately answer questions.

In addition to differing symptom presentations and health challenges during the COVID-19 pandemic, caretakers and medical professionals should be aware of older adults’ mental and emotional health.

The announcement is in response to ongoing reports of contamination with N-Nitrosodimethylamine (NDMA).

The collaboration will combine VBI’s viral vaccine experience and coronavirus antigens with the NRC’s unique COVID-19 antigens and assay development capabilities.

Study shows rivaroxaban (Xarelto, Bayer) following nonmajor orthopedic surgery reduced the risk of major venous thromboembolism by approximately 75% compared with enoxaparin.

Patients with symptomatic peripheral artery disease who took rivaroxaban (Xarelto, Bayer) saw a 15% reduction in the risk of major adverse limb and cardiovascular events.

The length of time patients remained contagious after the end of their symptoms, however, ranged from 1 to 8 days.

While the drugs are not currently FDA-approved for COVID-19, the FDA noted that they are recommended in some countries for COVID-19.

According to the researchers, the case fatality rate for patients with COVID-19 and cardiovascular disease is 10.5%.

Other therapeutic possibilities include a combination of HIV-1 protease inhibitors.

The researchers plan to present updated data at the European Society for Medical Oncology Breast Cancer conference in May.

Small cell lung cancer is highly aggressive and fast-growing, typically recurring and progressing rapidly despite the initial response to chemotherapy.

The letter was issued by the American Pharmacists Association, the Alliance for Pharmacy Compounding, the National Community Pharmacists Association, and the National Alliance of State Pharmacy Associations.

Study shows sleep apnea is significantly associated with increased risk of death among patients with advanced chronic kidney disease (CKD) and end-stage renal disease.

The waivers were approved within days of the states' submissions.

DCIS is a noninvasive condition in which abnormal cells are found in the lining of a breast duct but have not spread to other tissues in the breast.

The researchers noted that it is still important for people to cover their eyes, hands, and mouth to avoid virus particles spread from another person.

According to reporting by NPR, the decision may be in response to backlash from the health care community

Guidelines recommend that Ashkenazi Jewish women discuss genetic testing with physicians, but other women with breast cancer are less likely to receive a recommendation of testing.